Read More Pharma Industry News KROMATID secures $8m Series C funding to accelerate genomic structural analysis and gene therapy partnerships KROMATID raises $8M Series C to expand genomic structural analysis and gene therapy partnerships. Find out how this growth could reshape biotech. bySoujanya RaviAugust 20, 2025